Institution
Abertawe Bro Morgannwg University Health Board
Healthcare•Swansea, Wales [Cymru GB-CYM], United Kingdom•
About: Abertawe Bro Morgannwg University Health Board is a healthcare organization based out in Swansea, Wales [Cymru GB-CYM], United Kingdom. It is known for research contribution in the topics: Population & Medicine. The organization has 679 authors who have published 606 publications receiving 9213 citations.
Papers
More filters
TL;DR: Global health has steadily improved over the past 30 years as measured by age-standardised DALY rates, and there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries.
5,802 citations
Christopher J L Murray1, Christopher J L Murray2, Christopher J L Murray3, Aleksandr Y. Aravkin2 +2269 more•Institutions (286)
TL;DR: The largest declines in risk exposure from 2010 to 2019 were among a set of risks that are strongly linked to social and economic development, including household air pollution; unsafe water, sanitation, and handwashing; and child growth failure.
3,059 citations
TL;DR: In this interim analysis, the REGN-COV2 antibody cocktail reduced viral load, with a greater effect in patients whose immune response had not yet been initiated or who had a high viral load at baseline.
Abstract: Background Recent data suggest that complications and death from coronavirus disease 2019 (Covid-19) may be related to high viral loads. Methods In this ongoing, double-blind, phase 1–3 tr...
1,375 citations
University of Birmingham1, Newcastle University2, Weston Park Hospital3, University of Warwick4, Castle Hill Hospital5, Aberdeen Royal Infirmary6, Royal Surrey County Hospital7, Mount Sinai St. Luke's and Mount Sinai Roosevelt8, Cheltenham General Hospital9, Nottingham University Hospitals NHS Trust10, James Cook University Hospital11, Abertawe Bro Morgannwg University Health Board12, United Hospitals13, University Hospital Coventry14, Western General Hospital15, Beatson West of Scotland Cancer Centre16, VU University Amsterdam17, The Royal Marsden NHS Foundation Trust18, University of Oxford19
TL;DR: Cisplatin and radiotherapy should be used as the standard of care for HPV-positive low-risk patients who are able to tolerate cisplatin, and cetuximab showed significant detriment in terms of tumour control.
661 citations
Papworth Hospital1, Abertawe Bro Morgannwg University Health Board2, St James's University Hospital3, Newcastle University4, Manchester Royal Infirmary5, Western General Hospital6, National Institutes of Health7, Guy's and St Thomas' NHS Foundation Trust8, British Thoracic Society9, University of Manchester10, Great Ormond Street Hospital for Children NHS Foundation Trust11, Southmead Hospital12, Queen Alexandra Hospital13, University of Cambridge14
TL;DR: Recommendations and recommendations on what samples should be used to detect pulmonary non-tuberculous mycobacterial infection and how to define lung disease attributable to NTM infection are presented.
Abstract: Section 4: What is the evidence for transmission of NTM between individuals?
Recommendation
Section 5: How should the lung disease attributable to NTM infection be defined?
Recommendation
Good practice point
Section 6: What samples should be used to detect pulmonary non-tuberculous mycobacterial infection?
Recommendations
Good practice points
Section …
446 citations
Authors
Showing all 688 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Paul Willner | 58 | 210 | 16837 |
| David J Beard | 57 | 266 | 10651 |
| Stephen C. Bain | 48 | 250 | 11362 |
| Nicola S. Gray | 43 | 123 | 5089 |
| Julian Halcox | 43 | 161 | 18304 |
| Hao Chen | 42 | 244 | 6677 |
| Iain S. Whitaker | 41 | 267 | 5044 |
| Kristin Ladell | 39 | 115 | 4887 |
| Jeffrey W. Stephens | 36 | 166 | 4814 |
| Stephen D. Luzio | 35 | 160 | 4461 |
| Dietrich Mack | 32 | 51 | 4886 |
| Qinmei Wang | 31 | 182 | 3133 |
| Ian Thomas | 29 | 142 | 2600 |
| Jinhai Huang | 28 | 141 | 2591 |
| Paul Tae-Woo Lee | 26 | 109 | 1955 |